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Ethics (or moral philosophy) is defined as a field of 
expertise that involves “systematizing, defending, and 
recommending concepts of right and wrong behav-
iour” [1]. Within the context of medicine, ethics span 
across a major part of the decision-making process and 
are required to be cross cultural. In this paper, impor-
tant publications on two ethical issues that require both 
knowledge and self-awareness of the critical care physi-
cian are reviewed in brief.
Admission and discharge policies
Increasing patient age and complexity and the rising cost 
of intensive care make triage to intensive care a growing 
challenge. Given the shortage of beds, a policy of “watch-
ful waiting” may be viewed as prudent. However, Harris 
et  al. recently challenged this approach. Using instru-
mental variable analysis (and thereby elegantly bypass-
ing the need to correct for clinical patient condition) [2], 
they studied 12,380 intensive care unit (ICU) admissions 
in 48 United Kingdom hospitals and showed that admis-
sion within 4  h of triage was associated with improved 
survival but less common with increasing critical care 
bed occupancy [3]. Unfortunately, patient admission and 
discharge decisions are often driven by unseen causes. 
Anstey et  al. surveyed Californian doctors (n = 203) 
and nurses (n = 1101) and found significant differences 
(favouring inappropriate admission) between percep-
tions regarding the appropriateness of ICU admission 
and actual admission of patients who are either too well 
or too ill to benefit from intensive care [4]. Jerath et  al. 
discovered huge inequities in provision of post-operative 
ICU care in Canada (n = 541,524); older age and greater 
comorbidity was associated with more prompt ICU 
admission, but the interhospital admission rate varied 
100–200-fold for certain types of surgery, with unex-
plained local hospital practice accounting for much of 
this variation [5].
The price of redundant intensive care admission is 
difficult to quantify. Given the lack of beds, it is safe to 
assume that each redundant admission likely necessi-
tates a potentially early discharge. It is also reasonable 
to assume that less thoughtful admissions occur outside 
office hours when decisions are made by more junior 
staff and manpower is less abundant. Vollam et al. meta-
analysed data from 18 cohort studies (more than a mil-
lion patients) and showed that, regardless of healthcare 
setting or geographical location, discharge from the ICU 
outside of office hours was strongly associated with both 
in-hospital death and ICU readmission [6]. Redundant 
ICU care may be decreased by forgoing ICU admission 
altogether or by setting a time limit to the provision of 
ICU treatment. Based on their review of the literature, 
Vink et al. propose that a time-limited trial of ICU treat-
ment (TLT) be decided upon in selected patients at the 
time of ICU admission (i.e., when patient preference or 
the response to a treatment require elucidation), when 
complications occur during ICU stay or with a poor 
response to ICU care [7]. TLT decisions should ideally 
be made with the patient and/or their representative or 
at least be communicated to them. Sharing such infor-
mation lays the foundation for realistic care expectations 
and guarantees a climate conducive to interdisciplinary 
ethical reflection with subsequent decision-making, 
rather than focus on theoretical discussion alone.
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Can patient interests be aligned with those of the 
doctor or the medical system?
In most patient–physician interactions, patients choose 
their treating physician. The selection process itself 
engenders trust; the patient is unlikely to refer to a phy-
sician, whose judgment they do not value. In intensive 
care, this relation is born of necessity. This makes patients 
and relatives vulnerable to both perceived and real disre-
spect [8]. The paucity of evidence confirming the benefits 
of specific treatments in the complex ICU environment 
exacerbates the dilemmas [9]. This situation, combined 
with the limited resource of ICU care, requires that both 
the individual intensive care physician and our profession 
remain above reproach with regard to conflicts of inter-
ests (COIs) (Fig. 1).
As with any other problem, the first step towards 
overcoming COI requires that its existence be acknowl-
edged. Annane et al. put forward that COIs are integral 
to human nature, but often remain unrecognized by the 
individual. They proposed that medical schools teach 
identification and management of professional COIs and 
that institutions involved in the health sector have regu-
lations and policies for prevention and early detection of 
COIs. They also suggest that independent ethics boards 
should assess self-declared COIs before publication [10]. 
Such an arrangement would be ideal had medical school 
teachers and ethics committees not been comprised of 
humans with potential COIs of their own. In a narra-
tive review on COIs in infection prevention and control 
research, Abbas et al. demonstrated the all-pervasiveness 
of COIs, highlighting not only the relationship between 
industry and physicians, but also those with journal edi-
tors, guideline committee participants, and authors. They 
described the potentially devastating consequences of 
institutional COIs when these are torn between the need 
to report infection rates and the need to maintain a good 
public image, and the risk that COIs may distance guide-
lines from implementable practice [11].
Vincent et  al. argue that industry support boosts 
research and international collaboration [12]. While 
Fig. 1 Potential sources of conlict of interest
undoubtedly true, the question remains: at what other 
cost? Most writers of guidelines are funded by relevant 
industry [13, 14]. Claiming “everyone did it” does not 
make a wrong right. While it makes sense that experts in 
their field have a strong relationship with industry, this 
does not promote trust in the guidelines. In an almost 
biblical spirit—“(do) not come to call the righteous, but 
sinners to  repentance” [15]. Vincent et  al. also argue 
that if COIs are declared, trust is maintained. Still would 
most people not trust the righteous more than the sin-
ner? Furthermore, as succinctly noted by Brochard and 
Kavanagh, declarations of COIs also have limitations: 
they may change over time, create a false sense of full 
transparency, lead authors to feel absolved of responsibil-
ity towards integrity, and hide important relationships in 
full view [16]. Still, there is some hope for the future.
Zhang et  al. systematically analysed published RCTs 
comparing treatment with goal directed hemodynamic 
therapy or usual care to evaluate whether reported 
patient outcomes are related to the presence of COIs. 
Although 53% of the identified studies had COIs, the 
reported outcome was relatively neutral when industry 
involvement was limited to the loan of a device, but more 
positive in studies with author COIs or industry funding. 
[17]. This suggests that certain forms of industry sup-
port maintain objectivity. It behooves our community to 
identify, develop, and encourage these forms of support. 
Darmon et  al. searched four 1-month periods every 5 
years between 2001 and 2016 and showed that the rate 
of both COI statements and declared COI increased over 
time [18]. Our understanding of the potential impact 
of COIs is undoubtedly increasing. It is nice to see that 
with greater knowledge also comes a greater sense of 
responsibility.
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